# FDA Inspection 1175021 - Jean-Jacques Kiladjian, M.D., PhD - June 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/jean-jacques-kiladjian-md-phd/768877b7-bff9-4c73-8b90-1d36d4ce8274
Source feed: FDA_Inspections

> FDA Inspection 1175021 for Jean-Jacques Kiladjian, M.D., PhD on June 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175021
- Company Name: Jean-Jacques Kiladjian, M.D., PhD
- Inspection Date: 2022-06-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/jean-jacques-kiladjian-md-phd/ec4dc29b-13b2-4740-b568-a29448b1aa2b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c